Michelle M. Mielke, Ph.D. - Publications

Affiliations: 
2005 Johns Hopkins University, Baltimore, MD 
Area:
Mental Health, Epidemiology

314 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 van Kruining D, Losen M, Crivelli SM, de Jong JJA, Jansen JFA, Backes WH, Monereo-Sánchez J, van Boxtel MPJ, Köhler S, Linden DEJ, Schram MT, Mielke MM, Martinez-Martinez P. Plasma ceramides relate to mild cognitive impairment in middle-aged men: The Maastricht Study. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12459. PMID 37675435 DOI: 10.1002/dad2.12459  0.304
2023 Ramanan VK, Graff-Radford J, Syrjanen J, Shir D, Algeciras-Schimnich A, Lucas J, Martens YA, Carrasquillo MM, Day GS, Ertekin-Taner N, Lachner C, Willis FB, Knopman DS, Jack CR, Petersen RC, ... ... Mielke MM, et al. Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. Neurology. PMID 37580163 DOI: 10.1212/WNL.0000000000207675  0.33
2023 Kritikos M, Diminich ED, Meliker J, Mielke M, Bennett DA, Finch CE, Gandy SE, Carr MA, Yang X, Kotov R, Kuan PF, Bromet EJ, Clouston SAP, Luft BJ. Plasma amyloid beta 40/42, phosphorylated tau 181, and neurofilament light are associated with cognitive impairment and neuropathological changes among World Trade Center responders: A prospective cohort study of exposures and cognitive aging at midlife. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12409. PMID 36911360 DOI: 10.1002/dad2.12409  0.348
2023 Tian Q, Montero-Odasso M, Buchman AS, Mielke MM, Espinoza S, DeCarli CS, Newman AB, Kritchevsky SB, Rebok GW, Resnick SM, Thambisetty M, Verghese J, Ferrucci L. Dual cognitive and mobility impairments and future dementia - Setting a research agenda. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36637077 DOI: 10.1002/alz.12905  0.329
2022 Lutz MW, Khachaturian AS, Zetterberg H, Blennow K, Willette AA, Mielke MM, Hayden KM, Dodge HH, Tang Y, Greenberg BD, Kukull WA, Khachaturian ZS. Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36005812 DOI: 10.1002/alz.12772  0.515
2022 Carvalho DZ, St Louis EK, Przybelski SA, Morgenthaler TI, Machulda MM, Boeve BF, Petersen RC, Jack CR, Graff-Radford J, Vemuri P, Mielke MM. Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity. Frontiers in Aging Neuroscience. 14: 930315. PMID 35898322 DOI: 10.3389/fnagi.2022.930315  0.329
2022 Vassilaki M, Aakre JA, Castillo A, Chamberlain AM, Wilson PM, Kremers WK, Mielke MM, Geda YE, Machulda MM, Alhurani RE, Graff-Radford J, Vemuri P, Lowe VJ, Jack CR, Knopman DS, et al. Association of neighborhood socioeconomic disadvantage and cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35666244 DOI: 10.1002/alz.12702  0.305
2022 Ramanan VK, Heckman MG, Lesnick TG, Przybelski SA, Cahn EJ, Kosel ML, Murray ME, Mielke MM, Botha H, Graff-Radford J, Jones DT, Lowe VJ, Machulda MM, Jack CR, Knopman DS, et al. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease. Acta Neuropathologica. PMID 35412102 DOI: 10.1007/s00401-022-02419-2  0.31
2022 Jack CR, Therneau TM, Lundt ES, Wiste HJ, Mielke MM, Knopman DS, Graff-Radford J, Lowe VJ, Vemuri P, Schwarz CG, Senjem ML, Gunter JL, Petersen RC. Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk. Brain Communications. 4: fcac017. PMID 35310829 DOI: 10.1093/braincomms/fcac017  0.32
2022 Raghavan S, Przybelski SA, Reid RI, Lesnick TG, Ramanan VK, Botha H, Matchett BJ, Murray ME, Reichard RR, Knopman DS, Graff-Radford J, Jones DT, Lowe VJ, Mielke MM, Machulda MM, et al. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition. Acta Neuropathologica Communications. 10: 16. PMID 35123591 DOI: 10.1186/s40478-022-01319-6  0.331
2021 Li D, Zhang L, Nelson NW, Mielke MM, Yu F. Plasma Neurofilament Light and Future Declines in Cognition and Function in Alzheimer's Disease in the FIT-AD Trial. Journal of Alzheimer's Disease Reports. 5: 601-611. PMID 34514342 DOI: 10.3233/ADR-210302  0.312
2021 Wang X, Bui H, Vemuri P, Graff-Radford J, Jack CR, Petersen RC, Mielke MM. Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging. Journal of Alzheimer's Disease : Jad. PMID 33814434 DOI: 10.3233/JAD-201347  0.346
2021 Ramanan VK, Lesnick TG, Przybelski SA, Heckman MG, Knopman DS, Graff-Radford J, Lowe VJ, Machulda MM, Mielke MM, Jack CR, Petersen RC, Ross OA, Vemuri P. Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiology. Acta Neuropathologica Communications. 9: 48. PMID 33757599 DOI: 10.1186/s40478-021-01154-1  0.344
2021 Alden EC, Pudumjee SB, Lundt ES, Albertson SM, Machulda MM, Kremers WK, Jack CR, Knopman DS, Petersen RC, Mielke MM, Stricker NH. Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A T ) in a population-based sample. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33650308 DOI: 10.1002/alz.12219  0.303
2020 Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Vemuri P, Mielke MM, Whitwell J, et al. Predicting future rates of tau accumulation on PET. Brain : a Journal of Neurology. PMID 33094327 DOI: 10.1093/brain/awaa248  0.341
2020 Knopman DS, Lundt ES, Therneau TM, Albertson SM, Gunter JL, Senjem ML, Schwarz CG, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Vemuri P, Kantarci K, Lowe VJ, et al. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment. Jama Neurology. PMID 33074304 DOI: 10.1001/jamaneurol.2020.3921  0.314
2020 Cogswell PM, Wiste HJ, Senjem ML, Gunter JL, Weigand SD, Schwarz CG, Arani A, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Kantarci K, Vemuri P, ... ... Mielke MM, et al. Associations of Quantitative Susceptibility Mapping with Alzheimer's Disease Clinical and Imaging Markers. Neuroimage. 117433. PMID 33035667 DOI: 10.1016/j.neuroimage.2020.117433  0.308
2020 Raghavan S, Przybelski SA, Reid RI, Graff-Radford J, Lesnick TG, Zuk SM, Knopman DS, Machulda MM, Mielke MM, Petersen RC, Jack CR, Vemuri P. Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCI. Neurobiology of Aging. 96: 176-183. PMID 33022474 DOI: 10.1016/J.Neurobiolaging.2020.09.005  0.46
2020 Stricker NH, Christianson TJ, Lundt ES, Alden EC, Machulda MM, Fields JA, Kremers WK, Jack CR, Knopman DS, Mielke MM, Petersen RC. Mayo Normative Studies: Regression-Based Normative Data for the Auditory Verbal Learning Test for Ages 30-91 Years and the Importance of Adjusting for Sex. Journal of the International Neuropsychological Society : Jins. 1-16. PMID 32815494 DOI: 10.1017/S1355617720000752  0.303
2020 Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Mielke MM, Machulda MM, Stokin GB, Christianson TJ, Kremers WK, Jack CR, Knopman DS, Petersen RC, Geda YE. Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 32646634 DOI: 10.1016/J.Jagp.2020.06.006  0.37
2020 Stricker NH, Lundt ES, Albertson SM, Machulda MM, Pudumjee SB, Kremers WK, Jack CR, Knopman DS, Petersen RC, Mielke MM. Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 32538841 DOI: 10.3233/Jad-200087  0.442
2020 Hasan S, Mielke MM, Ahlskog JE, Bower J, Turcano P, Savica R. Infections or Sepsis Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32479692 DOI: 10.1002/Mds.28111  0.308
2020 Li D, Hagen C, Bui HH, Knopman D, Jack CR, Machulda M, Petersen RC, Mielke MM. Associations between cerebrospinal fluid total phosphatidylcholines, neurodegeneration, cognitive decline, and risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurobiology of Aging. 93: 52-54. PMID 32450444 DOI: 10.1016/J.Neurobiolaging.2020.04.020  0.443
2020 Machulda MM, Lundt ES, Albertson SM, Spychalla AJ, Schwarz CG, Mielke MM, Jack CR, Kremers WK, Vemuri P, Knopman DS, Jones DT, Bondi MW, Petersen RC. Cortical atrophy patterns of incident MCI subtypes in the Mayo Clinic Study of Aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32418367 DOI: 10.1002/Alz.12108  0.39
2020 Vassilaki M, Aakre JA, Kremers WK, Lesnick TG, Mielke MM, Geda YE, Machulda MM, Knopman DS, Butler L, Traber M, Vemuri P, Lowe VJ, Jack CR, Roberts RO, Petersen RC. Brain amyloid, cortical thickness, and changes in activities of daily living. Annals of Clinical and Translational Neurology. 7: 474-485. PMID 32314554 DOI: 10.1002/Acn3.51010  0.432
2020 Carvalho DZ, St Louis EK, Schwarz CG, Lowe VJ, Boeve BF, Przybelski SA, Reddy A, Mielke MM, Knopman DS, Petersen RC, Jack CR, Vemuri P. Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly. Neurology. PMID 32217775 DOI: 10.1212/Wnl.0000000000009315  0.368
2020 McCarter SJ, Stang C, Turcano P, Mielke MM, Ali F, Bower JH, Savica R. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia. Parkinsonism & Related Disorders. 73: 19-22. PMID 32203914 DOI: 10.1016/J.Parkreldis.2020.03.009  0.32
2020 Sprung J, Warner DO, Knopman DS, Petersen RC, Mielke MM, Jack CR, Lowe VJ, Martin DP, Hanson AC, Schroeder DR, Przybelski SA, Schulte PJ, Weingarten TN, Vemuri P. Exposure to surgery with general anaesthesia during adult life is not associated with increased brain amyloid deposition in older adults. British Journal of Anaesthesia. PMID 32171548 DOI: 10.1016/J.Bja.2020.01.015  0.312
2020 Vassilaki M, Syrjanen JA, Kremers WK, Hagen PT, Knopman DS, Mielke MM, Geda YE, Alhurani RE, Machulda MM, Roberts RO, Petersen RC. Medical Doctors and Dementia: A Longitudinal Study. Journal of the American Geriatrics Society. PMID 32086949 DOI: 10.1111/Jgs.16375  0.326
2020 Zeydan B, Lowe VJ, Reichard RR, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Parisi JE, Machulda MM, Vemuri P, Mielke MM, Knopman DS, Petersen RC, Jack CR, et al. Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis. Annals of Neurology. PMID 31970802 DOI: 10.1002/Ana.25684  0.318
2020 Arenaza-Urquijo EM, Przybelski SA, Machulda MM, Knopman DS, Lowe VJ, Mielke MM, Reddy AL, Geda YE, Jack CR, Petersen RC, Vemuri P. Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults. Neurology. PMID 31964689 DOI: 10.1212/Wnl.0000000000008979  0.376
2020 Li D, Mielke MM, Bell WR, Reilly C, Zhang L, Lin FV, Yu F. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial). Trials. 21: 19. PMID 31907024 DOI: 10.1186/S13063-019-3798-1  0.407
2020 Krell-Roesch J, Syrjanen JA, Vassilaki M, Woll A, Kremers WK, Machulda MM, Mielke MM, Knopman DS, Petersen RC, Geda YE. Late-life Physical Exercise, Neuropsychiatric Symptoms And The Risk Of Incident Mild Cognitive Impairment: 1299 Board #6 May 28 9:30 AM - 11:30 AM Medicine and Science in Sports and Exercise. 52: 339-340. DOI: 10.1249/01.Mss.0000677440.85436.77  0.341
2019 Neth BJ, Graff-Radford J, Mielke MM, Przybelski SA, Lesnick TG, Schwarz CG, Reid RI, Senjem ML, Lowe VJ, Machulda MM, Petersen RC, Jr CRJ, Knopman DS, Vemuri P. Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging. Frontiers in Aging Neuroscience. 11: 355. PMID 31998113 DOI: 10.3389/Fnagi.2019.00355  0.355
2019 Li D, Mielke MM. An Update on Blood-Based Markers of Alzheimer's Disease Using the SiMoA Platform. Neurology and Therapy. 8: 73-82. PMID 31833025 DOI: 10.1007/S40120-019-00164-5  0.36
2019 McCarter SJ, Tabatabai GM, Jong HY, Sandness DJ, Timm PC, Johnson KL, McCarter AR, Savica R, Vemuri P, Machulda MM, Kantarci K, Mielke MM, Boeve BF, Silber MH, St Louis EK. REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment. Neurology. PMID 31831602 DOI: 10.1212/Wnl.0000000000008694  0.313
2019 Alonso Quiñones HJ, Stish BJ, Hagen C, Petersen RC, Mielke MM. Prostate Cancer, Use of Androgen Deprivation Therapy, and Cognitive Impairment: A Population-based Study. Alzheimer Disease and Associated Disorders. PMID 31821185 DOI: 10.1097/Wad.0000000000000366  0.334
2019 Graff-Radford J, Lesnick T, Rabinstein AA, Gunter J, Aakre J, Przybelski SA, Spychalla AJ, Huston J, Brown RD, Mielke MM, Lowe VJ, Knopman DS, Petersen RC, Jack CR, Vemuri P, et al. Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging. Neurology. PMID 31801832 DOI: 10.1212/Wnl.0000000000008735  0.333
2019 Krell-Roesch J, Syrjanen JA, Vassilaki M, Barisch-Fritz B, Trautwein S, Boes K, Woll A, Kremers WK, Machulda MM, Mielke MM, Knopman DS, Petersen RC, Geda YE. Association of non-exercise physical activity in mid- and late-life with cognitive trajectories and the impact of APOE ε4 genotype status: the Mayo Clinic Study of Aging. European Journal of Ageing. 16: 491-502. PMID 31798373 DOI: 10.1007/S10433-019-00513-1  0.377
2019 Graff-Radford J, Gunter JL, Jones DT, Przybelski SA, Schwarz CG, Huston J, Lowe V, Elder BD, Machulda MM, Gunter NB, Petersen RC, Kantarci K, Vemuri P, Mielke MM, Knopman DS, et al. Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition. Neurology. PMID 31719134 DOI: 10.1212/Wnl.0000000000008616  0.415
2019 Maserejian N, Bian S, Wang W, Jaeger J, Syrjanen JA, Aakre J, Jack CR, Mielke MM, Gao F. Practical algorithms for amyloid β probability in subjective or mild cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 180. PMID 31700988 DOI: 10.1016/J.Dadm.2019.09.001  0.421
2019 Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Vemuri P, Machulda MM, Graff-Radford J, Knopman DS, Jack CR, Petersen RC, Kern S. Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31668594 DOI: 10.1016/J.Jalz.2019.07.009  0.31
2019 Yost M, Fiebelkorn CA, Rabinstein AA, Klaas J, Aakre JA, Brown RD, Mielke MM, Knopman DS, Lowe V, Petersen RC, Jack CR, Vemuri P, Graff-Radford J. Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 104451. PMID 31668581 DOI: 10.1016/J.Jstrokecerebrovasdis.2019.104451  0.329
2019 Sprung J, Abcejo ASA, Knopman DS, Petersen RC, Mielke MM, Hanson AC, Schroeder DR, Schulte PJ, Martin DP, Weingarten TN, Pasternak JJ, Warner DO. Anesthesia With and Without Nitrous Oxide and Long-term Cognitive Trajectories in Older Adults. Anesthesia and Analgesia. PMID 31651458 DOI: 10.1213/Ane.0000000000004490  0.31
2019 Scharf EL, Graff-Radford J, Przybelski SA, Lesnick TG, Mielke MM, Knopman DS, Preboske GM, Schwarz CG, Senjem ML, Gunter JL, Machulda M, Kantarci K, Petersen RC, Jack CR, Vemuri P. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging. Stroke. STROKEAHA119025822. PMID 31510903 DOI: 10.1161/Strokeaha.119.025822  0.368
2019 Mielke MM, Syrjanen JA, Bui HH, Petersen RC, Knopman DS, Jack CR, Graff-Radford J, Vemuri P. Elevated Plasma Ceramides Are Associated With Higher White Matter Hyperintensity Volume. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313099. PMID 31510790 DOI: 10.1161/Atvbaha.119.313099  0.3
2019 Vemuri P, Lesnick TG, Knopman DS, Przybelski SA, Reid RI, Mielke MM, Graff-Radford J, Lowe VJ, Machulda MM, Petersen RC, Jack CR. Amyloid, vascular, and resilience pathways associated with cognitive aging. Annals of Neurology. PMID 31509621 DOI: 10.1002/Ana.25600  0.418
2019 Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Lowe VJ, Vemuri P, Mielke MM, Fields JA, et al. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. Brain : a Journal of Neurology. PMID 31501889 DOI: 10.1093/Brain/Awz268  0.415
2019 Sprung J, Schulte PJ, Knopman DS, Mielke MM, Petersen RC, Weingarten TN, Martin DP, Hanson AC, Schroeder DR, Warner DO. Cognitive function after surgery with regional or general anesthesia: A population-based study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31495602 DOI: 10.1016/J.Jalz.2019.06.4949  0.325
2019 Vassilaki M, Aakre JA, Knopman DS, Kremers WK, Mielke MM, Geda YE, Machulda MM, Al Fakir R, Undavalli C, Roberts RO, Petersen RC. Informant-based hearing difficulties and the risk for mild cognitive impairment and dementia. Age and Ageing. PMID 31437275 DOI: 10.1093/Ageing/Afz099  0.415
2019 Goudarzvand S, St Sauver J, Mielke MM, Takahashi PY, Lee Y, Sohn S. Early temporal characteristics of elderly patient cognitive impairment in electronic health records. Bmc Medical Informatics and Decision Making. 19: 149. PMID 31391041 DOI: 10.1186/S12911-019-0858-0  0.318
2019 Jack CR, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, et al. Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework. Jama Neurology. PMID 31305929 DOI: 10.1001/Jamaneurol.2019.1971  0.403
2019 Krell-Roesch J, Syrjanen JA, Vassilaki M, Machulda MM, Mielke MM, Knopman DS, Kremers WK, Petersen RC, Geda YE. Quantity and quality of mental activities and the risk of incident mild cognitive impairment. Neurology. PMID 31292224 DOI: 10.1212/Wnl.0000000000007897  0.376
2019 Jack CR, Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Lowe VJ, Vemuri P, Machulda MM, Schwarz CG, Gunter JL, Senjem ML, Graff-Radford J, Jones DT, Roberts RO, et al. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. Jama. 321: 2316-2325. PMID 31211344 DOI: 10.1001/Jama.2019.7437  0.398
2019 Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, Gunter JL, Senjem ML, Przybelski SA, Lesnick T, Ward C, Mielke MM, Lowe VJ, Petersen RC, Kremers WK, et al. White matter hyperintensities: relationship to amyloid and tau burden. Brain : a Journal of Neurology. PMID 31199475 DOI: 10.1093/Brain/Awz162  0.369
2019 Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Vemuri P, Skoog I, Machulda MM, Kremers WK, Knopman DS, Jack C, Petersen RC, Kern S. Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures. Neurology. PMID 31182505 DOI: 10.1212/Wnl.0000000000007767  0.335
2019 Lowe VJ, Bruinsma TJ, Wiste HJ, Min HK, Weigand SD, Fang P, Senjem ML, Therneau TM, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, ... ... Mielke MM, et al. Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults. Neurology. PMID 31147421 DOI: 10.1212/Wnl.0000000000007728  0.384
2019 Machulda MM, Lundt ES, Albertson SM, Kremers WK, Mielke MM, Knopman DS, Bondi MW, Petersen RC. Neuropsychological subtypes of incident mild cognitive impairment in the Mayo Clinic Study of Aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31128864 DOI: 10.1016/J.Jalz.2019.03.014  0.417
2019 Schulte PJ, Warner DO, Martin DP, Deljou A, Mielke MM, Knopman DS, Petersen RC, Weingarten TN, Warner MA, Rabinstein AA, Hanson AC, Schroeder DR, Sprung J. Association Between Critical Care Admissions and Cognitive Trajectories in Older Adults. Critical Care Medicine. PMID 31107280 DOI: 10.1097/Ccm.0000000000003829  0.354
2019 Hasan S, Mielke MM, Ahlskog JE, Bower J, Turcano P, Savica R. Erectile Dysfunction Preceding Clinically Diagnosed -Synucleinopathies: A Case-Control Study in Olmsted County. Parkinson's Disease. 2019: 6303945. PMID 31093326 DOI: 10.1155/2019/6303945  0.311
2019 Li D, Hagen C, Fett AR, Bui HH, Knopman D, Vemuri P, Machulda MM, Jack CR, Petersen RC, Mielke MM. Longitudinal association between phosphatidylcholines, neuroimaging measures of Alzheimer's disease pathophysiology, and cognition in the Mayo Clinic Study of Aging. Neurobiology of Aging. 79: 43-49. PMID 31026621 DOI: 10.1016/J.Neurobiolaging.2019.03.005  0.432
2019 Li D, Misialek JR, Jack CR, Mielke MM, Knopman D, Gottesman R, Mosley T, Alonso A. Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities⁻Neurocognitive Study (ARIC-NCS). International Journal of Molecular Sciences. 20. PMID 30970556 DOI: 10.3390/Ijms20071744  0.329
2019 Krell-Roesch J, Vassilaki M, Mielke MM, Kremers WK, Lowe VJ, Vemuri P, Machulda MM, Christianson TJ, Syrjanen JA, Stokin GB, Butler LM, Traber M, Jack CR, Knopman DS, Roberts RO, et al. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging. Translational Psychiatry. 9: 123. PMID 30923322 DOI: 10.1038/S41398-019-0456-Z  0.404
2019 Arenaza-Urquijo EM, Przybelski SA, Lesnick TL, Graff-Radford J, Machulda MM, Knopman DS, Schwarz CG, Lowe VJ, Mielke MM, Petersen RC, Jack CR, Vemuri P. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies. Brain : a Journal of Neurology. PMID 30851100 DOI: 10.1093/Brain/Awz037  0.457
2019 Wennberg AM, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Machulda MM, Petrucelli L, Mielke MM, Jack CR, Knopman DS, Parisi JE, Petersen RC, Dickson DW, Josephs KA. The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals. Neurobiology of Aging. 77: 26-36. PMID 30776649 DOI: 10.1016/J.Neurobiolaging.2019.01.008  0.416
2019 Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Albertson SM, Schwarz CG, et al. Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects. Brain : a Journal of Neurology. PMID 30759182 DOI: 10.1093/Brain/Awz025  0.316
2019 Boeve A, Ferman TJ, Aakre J, St Louis E, Silber M, Machulda M, Fields J, Graff-Radford N, Mielke M, Geda Y, Jones D, Graff-Radford J, Knopman D, Petersen R, Boeve B. Excessive Daytime Sleepiness in Major Dementia Syndromes. American Journal of Alzheimer's Disease and Other Dementias. 1533317519828046. PMID 30740984 DOI: 10.1177/1533317519828046  0.399
2019 Krell-Roesch J, Syrjanen JA, Vassilaki M, Trautwein S, Barisch-Fritz B, Boes K, Woll A, Kremers WK, Machulda MM, Mielke MM, Knopman DS, Petersen RC, Geda YE. Physical Exercise, APOE E4 Genotype And Cognitive Trajectories: The Mayo Clinic Study Of Aging Medicine & Science in Sports & Exercise. 51: 473. DOI: 10.1249/01.Mss.0000561924.66614.C4  0.346
2019 Graff-Radford J, de Arenaza-Urquijo E, Schwarz C, Brown RD, Ward CP, Mielke MM, Przybelski S, Rabinstein AA, Lenick TG, Gunter JL, Petersen RC, Kantarci K, Knopman DS, Lowe V, Jack C, et al. Abstract 104: Topographic White Matter Hyperintensity Patterns Associated With Alzheimer Pathologies Stroke. 50. DOI: 10.1161/Str.50.Suppl_1.104  0.329
2019 Tian Q, Resnick S, Mielke M, Yaffe K, Rosano C, Simonsick EM, Studenski S, Ferrucci L. DUAL DECLINE IN MEMORY AND GAIT UNIQUELY IDENTIFIES OLDER PERSONS AT HIGH RISK OF DEMENTIA Innovation in Aging. 3: S586-S586. DOI: 10.1093/Geroni/Igz038.2173  0.418
2019 Carvalho D, St. Louis E, Lowe V, Schwarz C, Boeve B, Przybelski S, Reddy A, Mielke M, Knopman D, Petersen R, Jack C, Prashanthi V. tau-PET signal elevation in selective basal forebrain nuclei is associated with excessive daytime sleepiness in cognitively unimpaired middle aged and older adults Sleep Medicine. 64: S56-S57. DOI: 10.1016/J.Sleep.2019.11.155  0.361
2019 Corien van Harten A, Wiste HJ, Weigand SD, Mielke MM, Kremers WK, Eichenlaub U, Batrla-Utermann R, Dyer RB, Algeciras-Schimnic A, Knopman DS, Jack CR, Petersen RC. P4-537: DETECTION OF ALZHEIMER'S DISEASE IN CSF USING AUTOMATED ASSAYS FOR CLASSICAL CSF BIOMARKERS Alzheimer's & Dementia. 15: P1521-P1522. DOI: 10.1016/J.Jalz.2019.08.084  0.334
2019 Vemuri P, Przybelski SA, Lesnick TG, Graff-Radford J, Machulda MM, Reid RI, Mielke MM, Lowe VJ, Reddy AL, Petersen RC, Knopman DS, Jack CR. O3-04-01: BIOMARKERS FOR CAPTURING AMYLOID-INDEPENDENT EFFECTS OF VASCULAR HEALTH ON COGNITIVE DECLINE Alzheimer's & Dementia. 15: P885-P886. DOI: 10.1016/J.Jalz.2019.06.4642  0.366
2019 Krell-Roesch J, Syrjanen J, Harten ACv, Vassilaki M, Mielke MM, Vemuri P, Machulda MM, Lowe VJ, Jack CR, Kremers WK, Knopman DS, Stokin GB, Petersen RC, Geda YE. O2-11-01: Cross-Sectional Associations Between Csf Biomarkers Of Amyloid And Tau With Neuropsychiatric Symptoms: The Mayo Clinic Study Of Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4511  0.322
2019 Li D, Hagen CE, Bui HH, Vemuri P, Knopman DS, Jack CR, Petersen RC, Mielke MM. O2-05-05: CORRELATION OF CSF PHOSPHOLIPIDS AND ALZHEIMER'S DISEASE NEUROPATHOLOGY IN THE MAYO CLINIC STUDY OF AGING Alzheimer's & Dementia. 15: P547-P547. DOI: 10.1016/J.Jalz.2019.06.4479  0.362
2019 Jack CR, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, et al. O2-03-05: Prevalence Of Clinically Versus Biologically Defined Alzheimer'S Spectrum Entities Using The National Institute On Aging - Alzheimer'S Association Research Framework Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4467  0.36
2019 Arenaza-Urquijo EM, Przybelski SA, Machulda MM, Knopman DS, Lowe VJ, Mielke MM, Reddy AL, Geda YE, Jack CR, Petersen RC, Vemuri P. IC-P-160: STRESS: BETTER COPING ASSOCIATED WITH LOWER TAU IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P128-P128. DOI: 10.1016/J.Jalz.2019.06.4275  0.328
2019 Arenaza-Urquijo EM, Przybelski SA, Machulda MM, Knopman DS, Lowe VJ, Mielke MM, Reddy AL, Geda YE, Jack CR, Petersen RC, Vemuri P. P4-249: STRESS COPING ABILITY ASSOCIATED WITH TAU IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P1374-P1375. DOI: 10.1016/J.Jalz.2019.06.3912  0.351
2019 Dutt T, Vassilaki M, Christianson TJ, Knopman DS, Kremers WK, Mielke MM, Machulda MM, Geda YE, Undavalli C, Roberts RO, Petersen RC. P3-278: Chronic Kidney Disease And Risk Of Mild Cognitive Impairment Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3309  0.374
2018 Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, ... ... Mielke MM, et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30555031 DOI: 10.1016/J.Jalz.2018.09.009  0.371
2018 Petersen RC, Lundt ES, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Roberts RO, Lowe VJ, Machulda MM, Kremers WK, Geda YE, Jack CR. Predicting Progression to Mild Cognitive Impairment. Annals of Neurology. PMID 30521086 DOI: 10.1002/Ana.25388  0.445
2018 Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O'Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, et al. Current state of Alzheimer's fluid biomarkers. Acta Neuropathologica. 136: 821-853. PMID 30488277 DOI: 10.1007/S00401-018-1932-X  0.368
2018 Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Machulda MM, Knopman DS, Coloma PM, Schauble B, Vemuri P, Lowe VJ, Jack CR, Petersen RC, Roberts RO. Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia. Journal of the American Geriatrics Society. PMID 30462843 DOI: 10.1111/Jgs.15577  0.464
2018 Kern S, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Waern M, Hagen CE, van Harten AC, Knopman DS, Jack CR, Petersen RC, Mielke MM. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment. Jama Neurology. PMID 30419087 DOI: 10.1001/Jamaneurol.2018.3459  0.417
2018 Stricker NH, Lundt ES, Edwards KK, Machulda MM, Kremers WK, Roberts RO, Knopman DS, Petersen RC, Mielke MM. Comparison of PC and iPad administrations of the Cogstate Brief Battery in the Mayo Clinic Study of Aging: assessing cross-modality equivalence of computerized neuropsychological tests. The Clinical Neuropsychologist. 1-25. PMID 30417735 DOI: 10.1080/13854046.2018.1519085  0.335
2018 Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR, Petersen RC, Miller VM, ... Mielke MM, et al. Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration. Jama Neurology. PMID 30326011 DOI: 10.1001/Jamaneurol.2018.3057  0.418
2018 Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, Zuk SM, Senjem ML, Schwarz CG, Gunter JL, Kantarci K, Machulda MM, Mielke MM, Petersen RC, Knopman DS, et al. Development of a cerebrovascular MRI biomarker for cognitive aging. Annals of Neurology. PMID 30264411 DOI: 10.1002/Ana.25346  0.339
2018 Wennberg AMV, Hagen CE, Machulda MM, Knopman DS, Petersen RC, Mielke MM. The Cross-Sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 30256904 DOI: 10.1093/Gerona/Gly217  0.306
2018 Espeland MA, Carmichael O, Yasar S, Hugenschmidt C, Hazzard W, Hayden KM, Rapp SR, Neiberg R, Johnson KC, Hoscheidt S, Mielke MM. Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 1184-1192. PMID 30201101 DOI: 10.1016/J.Jalz.2018.05.015  0.569
2018 Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS. Sex and gender in Alzheimer's disease - Does it matter? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 1101-1103. PMID 30196887 DOI: 10.1016/J.Jalz.2018.08.003  0.567
2018 Ramanan VK, Przybelski SA, Graff-Radford J, Castillo AM, Lowe VJ, Mielke MM, Roberts RO, Reid RI, Knopman DS, Jack CR, Petersen RC, Vemuri P. Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30149450 DOI: 10.3233/Jad-180446  0.371
2018 Vassilaki M, Aakre JA, Kremers WK, Mielke MM, Geda YE, Alhurani RE, Dutt T, Machulda MM, Knopman DS, Vemuri P, Coloma PM, Schauble B, Lowe VJ, Jack CR, Petersen RC, et al. The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 30124772 DOI: 10.1093/Gerona/Gly149  0.464
2018 Krell-Roesch J, Cerhan LP, Machulda MM, Roberts RO, Mielke MM, Knopman DS, Syrjanen JA, Christianson TJ, Petersen RC, Geda YE. Functional Activity and Neuropsychiatric Symptoms in Normal Aging and Mild Cognitive Impairment: The Mayo Clinic Study of Aging. Alzheimer Disease and Associated Disorders. PMID 30106755 DOI: 10.1097/Wad.0000000000000266  0.374
2018 Chan P, Saleem M, Herrmann N, Mielke MM, Haughey NJ, Oh PI, Kiss A, Lanctôt KL. Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study. Journal of Alzheimer's Disease : Jad. PMID 30010121 DOI: 10.3233/Jad-180030  0.308
2018 van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO, Geda YE, Knopman DS, Petersen RC. Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging. Neurology. PMID 29959257 DOI: 10.1212/Wnl.0000000000005863  0.421
2018 Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L, Yu WH, Maki PM, Mielke MM. Understanding the impact of sex and gender in Alzheimer's disease: A call to action. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29907423 DOI: 10.1016/J.Jalz.2018.04.008  0.373
2018 Vassilaki M, Aakre JA, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Alhurani RE, Staubo SC, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO. Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers. Journal of Alzheimer's Disease : Jad. 64: 281-290. PMID 29889074 DOI: 10.3233/Jad-171121  0.371
2018 Wennberg AMV, Hagen CE, Edwards K, Roberts RO, Machulda MM, Knopman DS, Petersen RC, Mielke MM. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging. International Journal of Geriatric Psychiatry. PMID 29873112 DOI: 10.1002/Gps.4900  0.364
2018 Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS. New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29842864 DOI: 10.1016/J.Jalz.2018.05.002  0.577
2018 Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, Alhurani R, Geda YE, Machulda MM, Coloma P, Schauble B, Lowe VJ, Jack CR, Petersen RC. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting. Jama Neurology. PMID 29710225 DOI: 10.1001/Jamaneurol.2018.0629  0.366
2018 Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 532-534. PMID 29653605 DOI: 10.1016/J.Jalz.2018.03.003  0.542
2018 Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR, Petersen RC, Dage JL. Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29626426 DOI: 10.1016/J.Jalz.2018.02.013  0.364
2018 Krell-Roesch J, Feder NT, Roberts RO, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Geda YE. Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging. Journal of Alzheimer's Disease : Jad. PMID 29614667 DOI: 10.3233/Jad-171141  0.381
2018 Wennberg AMV, Hagen CE, Machulda MM, Hollman JH, Roberts RO, Knopman DS, Petersen RC, Mielke MM. The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging. Neurobiology of Aging. 66: 68-74. PMID 29547749 DOI: 10.1016/J.Neurobiolaging.2017.11.017  0.385
2018 Jack CR, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, et al. Longitudinal tau PET in ageing and Alzheimer's disease. Brain : a Journal of Neurology. PMID 29538647 DOI: 10.1093/Brain/Awy059  0.433
2018 Carvalho DZ, St Louis EK, Knopman DS, Boeve BF, Lowe VJ, Roberts RO, Mielke MM, Przybelski SA, Machulda MM, Petersen RC, Jack CR, Vemuri P. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia. Jama Neurology. PMID 29532057 DOI: 10.1001/Jamaneurol.2018.0049  0.448
2018 Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR. Joint associations of β-amyloidosis and cortical thickness with cognition. Neurobiology of Aging. 65: 121-131. PMID 29471214 DOI: 10.1016/J.Neurobiolaging.2018.01.017  0.432
2018 Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Mielke MM, Petersen RC, Jack CR, Vemuri P. Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly. Neurology. PMID 29343465 DOI: 10.1212/Wnl.0000000000004913  0.399
2018 Espeland MA, Carmichael OT, Yasar S, Hugenschmidt CE, Hazzard W, Hayden KM, Rapp SR, Neiberg RH, Johnson KC, Hoscheidt SM, Mielke MM. P1-624: Sex-Related Differences In Cognitive Impairment Among Overweight And Obese Adults With Type 2 Diabetes Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.637  0.54
2018 Li D, Hagen CE, Knopman DS, Jack CR, Petersen RC, Mielke MM. P3-221: Longitudinal Association Between Phosphatidylcholines, Neuroimaging Measures Of Alzheimer'S Disease Pathophysiology, And Cognition In The Mayo Clinic Study On Aging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1580  0.459
2017 Wennberg AMV, Lesnick TG, Schwarz CG, Savica R, Hagen CE, Roberts RO, Knopman DS, Hollman JH, Vemuri P, Jack CR, Petersen RC, Mielke MM. Longitudinal association between brain amyloid beta and gait in the Mayo Clinic Study of Aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 29236984 DOI: 10.1093/Gerona/Glx240  0.311
2017 Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, ... ... Mielke MM, et al. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Brain : a Journal of Neurology. PMID 29228201 DOI: 10.1093/Brain/Awx320  0.462
2017 Krell-Roesch J, Lowe VJ, Neureiter J, Pink A, Roberts RO, Mielke MM, Vemuri P, Stokin GB, Christianson TJ, Jack CR, Knopman DS, Boeve BF, Kremers WK, Petersen RC, Geda YE. Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging. International Psychogeriatrics. 1-7. PMID 29198244 DOI: 10.1017/S1041610217002368  0.371
2017 Mielke MM, Otto M. Neurofilaments in blood: (Almost) facing clinical application. Neurology. PMID 29070663 DOI: 10.1212/Wnl.0000000000004675  0.393
2017 Roberts RO, Knopman DS, Syrjanen JA, Aakre JA, Vassilaki M, Kremers WK, Mielke MM, Machulda MM, Graff-Radford J, Geda YE, Vemuri P, Lowe V, Jack CR, Petersen RC. Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers. Neurology. PMID 29030451 DOI: 10.1212/Wnl.0000000000004652  0.312
2017 Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, Roberts RO, Mielke MM, Machulda MM, Petersen RC, Jack CR. Age, Vascular Health, and Alzheimer's disease Biomarkers in an Elderly Sample. Annals of Neurology. PMID 29023983 DOI: 10.1002/Ana.25071  0.374
2017 Wennberg AMV, Schafer MJ, LeBrasseur NK, Savica R, Bui HH, Hagen CE, Hollman JH, Petersen RC, Mielke MM. Plasma Sphingolipids are Associated With Gait Parameters in the Mayo Clinic Study of Aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 28977376 DOI: 10.1093/Gerona/Glx139  0.318
2017 Martinez Martinez P, Mielke MM. Sphingolipids in Alzheimer's Disease and Related Disorders. Journal of Alzheimer's Disease : Jad. 60: 753-756. PMID 28922162 DOI: 10.3233/Jad-170735  0.319
2017 Mielke MM, Hagen CE, Wennberg AMV, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Jack CR, Petersen RC, Dage JL. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging. Jama Neurology. PMID 28692710 DOI: 10.1001/Jamaneurol.2017.1359  0.449
2017 Jung Y, Boot BP, Mielke MM, Ferman TJ, Geda YE, McDade E, Christianson TJH, Knopman DS, St Louis EK, Silber MH, Petersen RC, Boeve BF. Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 127-130. PMID 28649596 DOI: 10.1016/J.Dadm.2017.05.004  0.386
2017 Saleem M, Herrmann N, Dinoff A, Mielke MM, Oh PI, Shammi P, Cao X, Venkata SLV, Haughey NJ, Lanctôt KL. A Lipidomics Approach to Assess the Association between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise. Journal of Alzheimer's Disease : Jad. PMID 28598843 DOI: 10.3233/Jad-161292  0.326
2017 Vassilaki M, Christianson TJ, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO. Neuroimaging Biomarkers and Impaired Olfaction in Cognitively Normal Individuals. Annals of Neurology. PMID 28543731 DOI: 10.1002/Ana.24960  0.454
2017 Jack CR, Wiste HJ, Weigand SD, Therneau TM, Knopman DS, Lowe V, Vemuri P, Mielke MM, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. The Lancet. Neurology. PMID 28456479 DOI: 10.1016/S1474-4422(17)30077-7  0.43
2017 Vemuri P, Knopman DS, Lesnick TG, Przybelski SA, Mielke MM, Graff-Radford J, Murray ME, Roberts RO, Vassilaki M, Lowe VJ, Machulda MM, Jones DT, Petersen RC, Jack CR. Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals. Jama Neurology. PMID 28418521 DOI: 10.1001/Jamaneurol.2017.0244  0.363
2017 Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, Butts AM, Graff-Radford J, Lahr BD, Bailey KR, Miller VM. Preeclampsia and Cognitive Impairment Later in Life. American Journal of Obstetrics and Gynecology. PMID 28322777 DOI: 10.1016/J.Ajog.2017.03.008  0.353
2017 Wennberg AM, Savica R, Mielke MM. Association between Various Brain Pathologies and Gait Disturbance. Dementia and Geriatric Cognitive Disorders. 43: 128-143. PMID 28152532 DOI: 10.1159/000456541  0.365
2017 Krell-Roesch J, Vemuri P, Pink A, Roberts RO, Stokin GB, Mielke MM, Christianson TJ, Knopman DS, Petersen RC, Kremers WK, Geda YE. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype. Jama Neurology. PMID 28135351 DOI: 10.1001/Jamaneurol.2016.3822  0.395
2017 Graff-Radford J, Przybelski SA, Lesnick TG, Rabinstein A, Flemming K, Brown RD, Mielke MM, Spychalla AJ, Vemuri P, Lowe V, Knopman DS, Petersen RC, Jack CR, Kantarci K. Cerebral Microbleeds And Amyloid Burden: The Mayo Clinic Study Of Aging Alzheimers & Dementia. 13: 1237. DOI: 10.1016/J.Jalz.2017.07.440  0.325
2017 Knopman DS, Jack CR, Lundt ES, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Therneau TM, et al. CONTINUOUS MEASURES OF β-AMYLOIDOSIS AND CORTICAL THICKNESS IN RELATION TO COGNITIVE DECLINE IN COGNITIVELY NORMAL INDIVIDUALS: A POPULATION-BASED STUDY Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.105  0.378
2017 Wennberg AM, Lesnick TG, Schwarz CG, Knopman DS, Savica R, Hollman JH, Jack CR, Petersen RC, Mielke MM. [P1-457]: LONGITUDINAL ASSOCIATIONS BETWEEN CEREBRAL AMYLOID DEPOSITION, CORTICAL THICKNESS, AND GAIT IN THE MAYO CLINIC STUDY OF AGING Alzheimer's & Dementia. 13: P461-P462. DOI: 10.1016/J.Jalz.2017.06.473  0.321
2017 Boeve BF, Ross OA, Kantarci K, Ferman TJ, Graff-Radford NR, Radford JG, Jones DT, Savica R, Przybelski SA, Mielke MM, Knopman DS, Jack CR, Lowe V, Petersen RC. Characterization Of The Clinical And Neuroimaging Features Of Patients With Dementia With Lewy Bodies Associated With Variants In Glucocerebrosidase (Gba) Alzheimers & Dementia. 13: 384. DOI: 10.1016/J.Jalz.2017.06.350  0.315
2017 Corien van Harten A, Hagen CE, Edwards K, Mielke MM, Swenson-Dravis D, Knopman DS, Roberts RO, Geda YE, Petersen RC. [P4-179]: ASPECTS OF SUBJECTIVE COGNITIVE DECLINE THAT PREDICT INCIDENT MCI IN THE MAYO CLINC STUDY OF AGING Alzheimer's & Dementia. 13: P1331-P1331. DOI: 10.1016/J.Jalz.2017.06.2046  0.398
2017 Mielke MM, Hagen CE, Wennberg AM, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Lowe V, Jack CR, Petersen RC, Dage JL. [P3-242]: PLASMA TOTAL TAU, COGNITIVE DECLINE, AND RISK OF MILD COGNITIVE IMPAIRMENT IN THE MAYO CLINIC STUDY ON AGING Alzheimer's & Dementia. 13: P1032-P1033. DOI: 10.1016/J.Jalz.2017.06.1455  0.433
2017 Saleem M, Herrmann N, Dinoff A, Mielke MM, Oh PI, Shammi P, Cao X, Ratnam Bandaru VV, Haughey NJ, Lanctot KL, Li A. [P3-239]: A LIPIDOMICS APPROACH TO ASSESS PLASMA SPHINGOLIPIDS AS PREDICTORS OF VERBAL MEMORY PERFORMANCE IN CORONARY ARTERY DISEASE PATIENTS UNDERTAKING CARDIAC REHABILITATION: A C18:0 SIGNATURE FOR COGNITIVE RESPONSE TO EXERCISE Alzheimer's & Dementia. 13: P1031-P1031. DOI: 10.1016/J.Jalz.2017.06.1452  0.303
2017 Dinoff A, Saleem M, Herrmann N, Haughey NJ, Oh PI, Mielke MM, Lanctot KL. [P3-210]: PLASMA SPHINGOLIPID RATIOS AND VERBAL MEMORY PERFORMANCE IN A CORONARY ARTERY DISEASE POPULATION AT RISK FOR VASCULAR COGNITIVE IMPAIRMENT (VCI) AND ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1016-P1017. DOI: 10.1016/J.Jalz.2017.06.1423  0.384
2016 Carvalho DZ, St Louis EK, Boeve BF, Mielke MM, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Geda YE, Petersen RC, Jack CR, Vemuri P. Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults. Sleep Medicine. PMID 28065685 DOI: 10.1016/J.Sleep.2016.08.023  0.35
2016 Mielke MM, Haughey NJ, Han D, An Y, Bandaru VV, Lyketsos CG, Ferrucci L, Resnick SM. The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging. Journal of Alzheimer's Disease : Jad. PMID 28035934 DOI: 10.3233/Jad-160925  0.452
2016 O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27870940 DOI: 10.1016/J.Jalz.2016.09.014  0.337
2016 Krell-Roesch J, Pink A, Roberts RO, Stokin GB, Mielke MM, Spangehl KA, Bartley MM, Knopman DS, Christianson TJ, Petersen RC, Geda YE. Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment. Journal of the American Geriatrics Society. PMID 27801933 DOI: 10.1111/Jgs.14402  0.38
2016 Machulda MM, Hagen CE, Wiste HJ, Mielke MM, Knopman DS, Roberts RO, Vemuri P, Lowe VJ, Jack CR, Petersen RC. Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status. The Clinical Neuropsychologist. 1-19. PMID 27724156 DOI: 10.1080/13854046.2016.1241303  0.425
2016 Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes D, et al. Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27697430 DOI: 10.1016/J.Jalz.2016.08.005  0.301
2016 Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J, Rapp PR, Yaffe K, Carrillo MC. Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27692800 DOI: 10.1016/J.Jalz.2016.08.004  0.37
2016 Savica R, Wennberg AM, Hagen C, Edwards K, Roberts RO, Hollman JH, Knopman DS, Boeve BF, Machulda MM, Petersen RC, Mielke MM. Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging. Journal of Alzheimer's Disease : Jad. PMID 27662317 DOI: 10.3233/Jad-160697  0.392
2016 Pink A, Przybelski SA, Krell-Roesch J, Stokin GB, Roberts RO, Mielke MM, Spangehl KA, Knopman DS, Jack CR, Petersen RC, Geda YE. Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych151003. PMID 27578447 DOI: 10.1176/Appi.Neuropsych.15100378  0.319
2016 Staubo SC, Aakre JA, Vemuri P, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Jack CR, Roberts RO. Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27461490 DOI: 10.1016/J.Jalz.2016.06.2359  0.349
2016 Knopman DS, Jack CR, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC. Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum. Neurobiology of Aging. 46: 32-42. PMID 27460147 DOI: 10.1016/J.Neurobiolaging.2016.06.003  0.42
2016 Krell-Roesch J, Ruider H, Lowe VJ, Stokin GB, Pink A, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Machulda MM, Jack CR, Petersen RC, Geda YE. FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging. Journal of Alzheimer's Disease : Jad. PMID 27447426 DOI: 10.3233/Jad-160326  0.381
2016 Dage JL, Wennberg AM, Airey DC, Hagen CE, Knopman DS, Machulda MM, Roberts RO, Jack CR, Petersen RC, Mielke MM. Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27436677 DOI: 10.1016/J.Jalz.2016.06.001  0.373
2016 Knopman DS, Jack CR, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC. Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia. Neurology. PMID 27421543 DOI: 10.1212/Wnl.0000000000002979  0.411
2016 Gonzalez CE, Venkatraman VK, An Y, Landman BA, Davatzikos C, Ratnam Bandaru VV, Haughey NJ, Ferrucci L, Mielke MM, Resnick SM. Peripheral sphingolipids are associated with variation in white matter microstructure in older adults. Neurobiology of Aging. 43: 156-63. PMID 27255825 DOI: 10.1016/J.Neurobiolaging.2016.04.008  0.322
2016 Vassilaki M, Aakre JA, Mielke MM, Geda YE, Kremers WK, Alhurani RE, Machulda MM, Knopman DS, Petersen RC, Lowe VJ, Jack CR, Roberts RO. Multimorbidity and neuroimaging biomarkers among cognitively normal persons. Neurology. PMID 27164657 DOI: 10.1212/Wnl.0000000000002624  0.385
2016 Kantarci K, Lowe VJ, Lesnick TG, Tosakulwong N, Bailey KR, Fields JA, Shuster LT, Zuk SM, Senjem ML, Mielke MM, Gleason C, Jack CR, Rocca WA, Miller VM. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. Journal of Alzheimer's Disease : Jad. PMID 27163830 DOI: 10.3233/Jad-160258  0.319
2016 Wennberg AM, Gustafson D, Hagen CE, Roberts RO, Knopman D, Jack C, Petersen RC, Mielke MM. Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging. Journal of Alzheimer's Disease : Jad. PMID 27163809 DOI: 10.3233/Jad-151201  0.473
2016 Savica R, Murray ME, Persson XM, Kantarci K, Parisi JE, Dickson DW, Petersen RC, Ferman TJ, Boeve BF, Mielke MM. Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 43-50. PMID 27152320 DOI: 10.1016/J.Dadm.2016.02.005  0.379
2016 Fabbri E, Yang A, Simonsick EM, Chia CW, Zoli M, Haughey NJ, Mielke MM, Ferrucci L, Coen PM. Circulating ceramides are inversely associated with cardiorespiratory fitness in participants aged 54-96 years from the Baltimore Longitudinal Study of Aging. Aging Cell. PMID 27135629 DOI: 10.1111/Acel.12491  0.309
2016 Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, Mielke MM, Roberts RO, Gunter JL, Senjem ML, Geda YE, Rocca WA, Petersen RC, Jack CR. Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study. Neurology. PMID 26911640 DOI: 10.1212/Wnl.0000000000002490  0.409
2016 Mielke MM, Milic NM, Weissgerber TL, White WM, Kantarci K, Mosley TH, Windham BG, Simpson BN, Turner ST, Garovic VD. Impaired Cognition and Brain Atrophy Decades After Hypertensive Pregnancy Disorders. Circulation. Cardiovascular Quality and Outcomes. 9: S70-6. PMID 26908863 DOI: 10.1161/Circoutcomes.115.002461  0.319
2016 Alhurani RE, Vassilaki M, Aakre JA, Mielke MM, Kremers WK, Machulda MM, Geda YE, Knopman DS, Peterson RC, Roberts RO. Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging. Jama Neurology. PMID 26831542 DOI: 10.1001/Jamaneurol.2015.4756  0.411
2016 Knopman DS, Wiste HJ, Jack CR, Petersen RC, Boeve BF, Kantarci K, Jones DT, Mielke MM, Roberts RO, Weigand SD, Graff-Radford J, Vemuri P, Machulda MM, Lowe VJ. Av1451 Pet Imaging In The Spectrum Of Alzheimer’S Disease From Clinically Normal To Dementia Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.436  0.332
2016 Mielke MM. S1-01-02: Differences Between Men and Women in the Risk of Dementia Alzheimer's & Dementia. 12: P161-P161. DOI: 10.1016/J.Jalz.2016.06.268  0.305
2016 Wennberg AM, Savica R, Hagen CE, Roberts RO, Knopman DS, Jack CR, Petersen RC, Mielke MM. P3-268: Cerebral Amyloid Deposition is Associated with Poorer Gait in Cognitively Normal Late-Middle Aged Individuals: the Mayo Clinic Study of Aging Alzheimer's & Dementia. 12: P935-P935. DOI: 10.1016/J.Jalz.2016.06.1931  0.399
2016 Krell-Roesch J, Pink A, Stokin GB, Roberts RO, Mielke MM, Vemuri P, Christianson TJ, Lowe VJ, Jack CR, Boeve BF, Petersen RC, Geda YE. P2-178: Amyloid-B, Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging Alzheimer's & Dementia. 12: P685-P686. DOI: 10.1016/J.Jalz.2016.06.1345  0.412
2015 Graff-Radford J, Madhavan M, Vemuri P, Rabinstein AA, Cha RH, Mielke MM, Kantarci K, Lowe V, Senjem ML, Gunter JL, Knopman DS, Petersen RC, Jack CR, Roberts RO. Atrial fibrillation, cognitive impairment, and neuroimaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26607820 DOI: 10.1016/J.Jalz.2015.08.164  0.425
2015 Mielke MM, Machulda MM, Hagen CE, Christianson TJ, Roberts RO, Knopman DS, Vemuri P, Lowe VJ, Kremers WK, Jack CR, Petersen RC. Influence of amyloid and apolipoprotein E on cognitive performance in a late middle-aged cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26602629 DOI: 10.1016/J.Jalz.2015.09.010  0.407
2015 Jack CR, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Mielke MM, Vemuri P, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC. Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. The Lancet. Neurology. PMID 26597325 DOI: 10.1016/S1474-4422(15)00323-3  0.358
2015 Petersen RC, Wiste HJ, Weigand SD, Rocca WA, Roberts RO, Mielke MM, Lowe VJ, Knopman DS, Pankratz VS, Machulda MM, Geda YE, Jack CR. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community. Jama Neurology. 1-8. PMID 26595683 DOI: 10.1001/Jamaneurol.2015.3098  0.457
2015 Roberts RO, Christianson TJ, Kremers WK, Mielke MM, Machulda MM, Vassilaki M, Alhurani RE, Geda YE, Knopman DS, Petersen RC. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. Jama Neurology. 1-9. PMID 26569387 DOI: 10.1001/Jamaneurol.2015.2952  0.458
2015 Knopman DS, Beiser A, Machulda MM, Fields J, Roberts RO, Pankratz VS, Aakre J, Cha RH, Rocca WA, Mielke MM, Boeve BF, Devine S, Ivnik RJ, Au R, Auerbach S, et al. Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging. Neurology. 85: 1712-21. PMID 26453643 DOI: 10.1212/Wnl.0000000000002100  0.436
2015 Roberts RO, Aakre JA, Cha RH, Kremers WK, Mielke MM, Velgos SN, Geda YE, Knopman DS, Petersen RC. Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele. Frontiers in Aging Neuroscience. 7: 172. PMID 26441635 DOI: 10.3389/Fnagi.2015.00172  0.371
2015 Knopman DS, Jack CR, Lundt ES, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, et al. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment. Jama Neurology. 1-9. PMID 26437123 DOI: 10.1001/Jamaneurol.2015.2323  0.41
2015 Jack CR, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, Lowe V, Senjem ML, Gunter JL, Reyes D, Machulda MM, Roberts R, Petersen RC. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings. Brain : a Journal of Neurology. PMID 26428666 DOI: 10.1093/Brain/Awv283  0.321
2015 Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, Buckley RF, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Katz MJ, Lipton RB, ... ... Mielke MM, et al. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures used Across 19 International Research Studies. Journal of Alzheimer's Disease : Jad. PMID 26402085 DOI: 10.3233/Jad-150154  0.366
2015 Vassilaki M, Aakre JA, Cha RH, Kremers WK, St Sauver JL, Mielke MM, Geda YE, Machulda MM, Knopman DS, Petersen RC, Roberts RO. Multimorbidity and Risk of Mild Cognitive Impairment. Journal of the American Geriatrics Society. 63: 1783-90. PMID 26311270 DOI: 10.1111/Jgs.13612  0.417
2015 Mielke MM, Bandaru VV, Han D, An Y, Resnick SM, Ferrucci L, Haughey NJ. Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species. Aging Cell. PMID 26193443 DOI: 10.1111/Acel.12369  0.325
2015 Mielke MM, Machulda MM, Hagen CE, Edwards KK, Roberts RO, Pankratz VS, Knopman DS, Jack CR, Petersen RC. Performance of the CogState computerized battery in the Mayo Clinic Study on Aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25858683 DOI: 10.1016/J.Jalz.2015.01.008  0.38
2015 Roberts RO, Cha RH, Mielke MM, Geda YE, Boeve BF, Machulda MM, Knopman DS, Petersen RC. Risk and protective factors for cognitive impairment in persons aged 85 years and older. Neurology. 84: 1854-61. PMID 25854867 DOI: 10.1212/Wnl.0000000000001537  0.387
2015 Pankratz VS, Roberts RO, Mielke MM, Knopman DS, Jack CR, Geda YE, Rocca WA, Petersen RC. Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurology. 84: 1433-42. PMID 25788555 DOI: 10.1212/Wnl.0000000000001437  0.419
2015 Jack CR, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, Gregg BE, Pankratz VS, Rocca WA, Petersen RC. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. Jama Neurology. 72: 511-9. PMID 25775353 DOI: 10.1001/Jamaneurol.2014.4821  0.393
2015 Vassilaki M, Cha RH, Aakre JA, Therneau TM, Geda YE, Mielke MM, Knopman DS, Petersen RC, Roberts RO. Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging. Journal of Alzheimer's Disease : Jad. 45: 1237-45. PMID 25697699 DOI: 10.3233/Jad-143078  0.398
2015 Pink A, Stokin GB, Bartley MM, Roberts RO, Sochor O, Machulda MM, Krell-Roesch J, Knopman DS, Acosta JI, Christianson TJ, Pankratz VS, Mielke MM, Petersen RC, Geda YE. Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study. Neurology. 84: 935-43. PMID 25653291 DOI: 10.1212/Wnl.0000000000001307  0.399
2015 Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Preboske GM, Kantarci K, Raman MR, Machulda MM, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Rocca WA, Roberts RO, Petersen RC, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain : a Journal of Neurology. 138: 761-71. PMID 25595145 DOI: 10.1093/Brain/Awu393  0.454
2015 Mielke MM, Bandaru VV, Han D, An Y, Resnick SM, Ferrucci L, Haughey NJ. Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging. Aging Cell. 14: 112-21. PMID 25345489 DOI: 10.1111/Acel.12275  0.309
2015 Nowrangi MA, Okonkwo O, Lyketsos C, Oishi K, Mori S, Albert M, Mielke MM. Atlas-based diffusion tensor imaging correlates of executive function. Journal of Alzheimer's Disease : Jad. 44: 585-98. PMID 25318544 DOI: 10.3233/Jad-141937  0.361
2015 Pink A, Przybelski S, Krell-Roesch J, Stokin G, Spangehl K, Roberts R, Mielke M, Knopman D, Jack C, Petersen R, Geda Y. Cortical thickness, anxiety and depressive symptoms in normal cognitive aging: the Mayo Clinic Study of Aging Journal of the Neurological Sciences. 357: e228. DOI: 10.1016/J.Jns.2015.08.785  0.331
2015 Vemuri P, Lesnick TG, Przybelski SA, Machulda MM, Knopman DS, Mielke M, Roberts R, Lowe VJ, Rocca W, Geda YE, Petersen RC, Jack CR. F5-01-03: Better intellectual lifestyle to keep cognitive impairment away Alzheimer's & Dementia. 11: P303-P304. DOI: 10.1016/J.Jalz.2015.07.425  0.348
2015 Krell-Roesch J, Pink A, Roberts RO, Mielke MM, Christianson TJ, Knopman DS, Stokin GB, Petersen RC, Geda YE. O3-11-06: Caloric intake and the risk of mild cognitive impairment: A population-based cohort study Alzheimer's & Dementia. 11: P246-P246. DOI: 10.1016/J.Jalz.2015.07.302  0.371
2015 Mielke MM, Machulda MM, Hagen CE, Christianson TJ, Roberts RO, Knopman DS, Vemuri P, Lowe VJ, Jack CR, Petersen RC. P2-167: Influence of amyloid and APOE genotype on cognitive performance in a middle-aged cohort Alzheimer's & Dementia. 11: P553-P553. DOI: 10.1016/J.Jalz.2015.06.706  0.413
2015 Boeve AR, Ferman TJ, Aakre JA, Louis EKS, Silber MH, Machulda MM, Fields JA, Graff-Radford N, Mielke MM, Geda YE, Jones DT, Radford JG, Knopman DS, Petersen RC, Boeve B. Excessive daytime sleepiness is comparable in behavioral variant frontotemporal dementia and Alzheimer's disease dementia but greater in dementia with lewy bodies Alzheimers & Dementia. 11: 392. DOI: 10.1016/J.Jalz.2015.06.329  0.389
2014 Mielke MM, Weigand SD, Wiste HJ, Vemuri P, Machulda MM, Knopman DS, Lowe V, Roberts RO, Kantarci K, Rocca WA, Jack CR, Petersen RC. Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 779-89. PMID 25458308 DOI: 10.1016/J.Jalz.2014.09.001  0.391
2014 Jack CR, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. The Lancet. Neurology. 13: 997-1005. PMID 25201514 DOI: 10.1016/S1474-4422(14)70194-2  0.412
2014 Vemuri P, Lesnick TG, Przybelski SA, Machulda M, Knopman DS, Mielke MM, Roberts RO, Geda YE, Rocca WA, Petersen RC, Jack CR. Association of lifetime intellectual enrichment with cognitive decline in the older population. Jama Neurology. 71: 1017-24. PMID 25054282 DOI: 10.1001/Jamaneurol.2014.963  0.378
2014 Rocca WA, Mielke MM, Vemuri P, Miller VM. Sex and gender differences in the causes of dementia: a narrative review. Maturitas. 79: 196-201. PMID 24954700 DOI: 10.1016/J.Maturitas.2014.05.008  0.317
2014 Mielke MM, Haughey NJ, Bandaru VV, Zetterberg H, Blennow K, Andreasson U, Johnson SC, Gleason CE, Blazel HM, Puglielli L, Sager MA, Asthana S, Carlsson CM. Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease. Neurobiology of Aging. 35: 2486-94. PMID 24952994 DOI: 10.1016/J.Neurobiolaging.2014.05.019  0.38
2014 Knopman DS, Roberts RO, Pankratz VS, Cha RH, Rocca WA, Mielke MM, Boeve BF, Tangalos EG, Ivnik RJ, Geda YE, Petersen RC. Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. American Journal of Epidemiology. 180: 414-23. PMID 24859276 DOI: 10.1093/Aje/Kwu103  0.383
2014 Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 844-52. PMID 24798886 DOI: 10.1016/J.Jalz.2014.01.001  0.436
2014 Jack CR, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC. Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 82: 1605-12. PMID 24706010 DOI: 10.1212/Wnl.0000000000000386  0.346
2014 Knopman DS, Jack CR, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiology of Aging. 35: 2096-106. PMID 24702820 DOI: 10.1016/J.Neurobiolaging.2014.03.006  0.397
2014 Geda YE, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Sochor O, Tangalos EG, Petersen RC, Rocca WA. Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. The American Journal of Psychiatry. 171: 572-81. PMID 24700290 DOI: 10.1176/Appi.Ajp.2014.13060821  0.409
2014 Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ, Rocca WA, Petersen RC, Jack CR. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 82: 1132-41. PMID 24647028 DOI: 10.1212/Wnl.0000000000000269  0.37
2014 Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, Geda YE, Christianson TJ, Pankratz VS, Petersen RC. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. Jama Neurology. 71: 581-8. PMID 24637951 DOI: 10.1001/Jamaneurol.2014.94  0.38
2014 Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clinical Epidemiology. 6: 37-48. PMID 24470773 DOI: 10.2147/Clep.S37929  0.403
2014 Mielke MM, Savica R, Wiste HJ, Weigand SD, Vemuri P, Knopman DS, Lowe VJ, Roberts RO, Machulda MM, Geda YE, Petersen RC, Jack CR. Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study. Neurology. 82: 70-6. PMID 24371306 DOI: 10.1212/01.Wnl.0000438229.56094.54  0.407
2014 Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S, Mielke MM, O'Bryant S, Sarasa M, Sjøgren M, Soares H, Teeling J, Trushina E, Ward M, West T, et al. Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 109-14. PMID 24365657 DOI: 10.1016/J.Jalz.2013.10.007  0.355
2014 Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA, Petersen RC. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 82: 317-25. PMID 24353333 DOI: 10.1212/Wnl.0000000000000055  0.435
2014 Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, Roberts RO. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. Journal of Alzheimer's Disease : Jad. 39: 271-82. PMID 24164735 DOI: 10.3233/Jad-130830  0.4
2014 Trushina E, Mielke MM. Recent advances in the application of metabolomics to Alzheimer's Disease. Biochimica Et Biophysica Acta. 1842: 1232-9. PMID 23816564 DOI: 10.1016/J.Bbadis.2013.06.014  0.389
2014 Steinberg M, Hess K, Corcoran C, Mielke MM, Norton M, Breitner J, Green R, Leoutsakos J, Welsh-Bohmer K, Lyketsos C, Tschanz J. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. International Journal of Geriatric Psychiatry. 29: 153-9. PMID 23681754 DOI: 10.1002/Gps.3980  0.344
2014 Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Baertlein L, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, Petersen RC. Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 18-26. PMID 23562428 DOI: 10.1016/J.Jalz.2013.01.001  0.427
2014 Feder NT, Bartley MM, Acosta JI, Roberts RO, Knopman DS, Christianson TJ, Pankratz VS, Mielke MM, Stokin GB, Lowe VJ, Petersen RC, Geda YE. Physical Exercise And The Outcome Of Incident Dementia: The Mayo Clinic Study Of Aging Alzheimers & Dementia. 10: 527. DOI: 10.1016/J.Jalz.2014.05.829  0.303
2014 Boeve A, Mielke MM, Geda Y, Roberts RO, Ivnik R, Machulda MM, Fields JA, Pankratz V, Boeve BF, Knopman DS, Petersen R. P1-323: SLEEP-RELATED FEATURES AND PERFORMANCE ON A COMPUTERIZED COGNITIVE BATTERY: THE MAYO CLINIC STUDY OF AGING Alzheimer's & Dementia. 10: P430-P430. DOI: 10.1016/J.Jalz.2014.05.564  0.335
2014 Mielke MM, Hagen C, Roberts RO, Vemuri P, Machulda MM, Christianson T, Pankratz VS, Knopman DS, Lowe VJ, Jack C, Petersen R. P4-089: SELF- AND INFORMANT-RATED DAILY FUNCTION IS ASSOCIATED WITH AMYLOID AND NEURODEGENERATIVE IMAGING IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 10: P816-P816. DOI: 10.1016/J.Jalz.2014.05.1604  0.358
2014 Machulda MM, Hagen C, Mielke MM, Christianson T, Pankratz V, Jack C, Lowe VJ, Ivnik R, Roberts RO, Knopman DS, Petersen RC. O2-10-02: PRACTICE EFFECTS AND LONGITUDINAL COGNITIVE CHANGE AS A FUNCTION OF AMYLOID AND NEURODEGENERATIVE IMAGING BIOMARKERS IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 10: P186-P186. DOI: 10.1016/J.Jalz.2014.04.211  0.396
2014 Roberts RO, Cha RH, Geda Y, Pankratz VS, Boeve BF, Mielke MM, Machulda MM, Knopman DS, Petersen RC. Predictors And Protective Factors For Cognitive Impairment In Very Old Cognitively Normal Persons Alzheimers & Dementia. 10: 151. DOI: 10.1016/J.Jalz.2014.04.118  0.386
2014 Hollas CN, Geda Y, Petersen RC, Mielke MM. Is Exercise in Early- and Mid-Adulthood Associated With Cognition in Mid-Life? The American Journal of Geriatric Psychiatry. 22: S102-S103. DOI: 10.1016/J.Jagp.2013.12.117  0.326
2013 Saleem M, Ratnam Bandaru VV, Herrmann N, Swardfager W, Mielke MM, Oh PI, Shammi P, Kiss A, Haughey NJ, Rovinski R, Lanctôt KL. Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study. Bmc Geriatrics. 13: 135. PMID 24330446 DOI: 10.1186/1471-2318-13-135  0.323
2013 Sachdev PS, Lipnicki DM, Kochan NA, Crawford JD, Rockwood K, Xiao S, Li J, Li X, Brayne C, Matthews FE, Stephan BC, Lipton RB, Katz MJ, Ritchie K, Carrière I, ... ... Mielke MM, et al. COSMIC (Cohort Studies of Memory in an International Consortium): an international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups. Bmc Neurology. 13: 165. PMID 24195705 DOI: 10.1186/1471-2377-13-165  0.437
2013 Jack CR, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC. Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology. 81: 1732-40. PMID 24132377 DOI: 10.1212/01.Wnl.0000435556.21319.E4  0.358
2013 Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, Gasser T, Hauser AK, Gräber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study. Plos One. 8: e73094. PMID 24058461 DOI: 10.1371/Journal.Pone.0073094  0.353
2013 Machulda MM, Pankratz VS, Christianson TJ, Ivnik RJ, Mielke MM, Roberts RO, Knopman DS, Boeve BF, Petersen RC. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging. The Clinical Neuropsychologist. 27: 1247-64. PMID 24041121 DOI: 10.1016/J.Jalz.2013.05.1632  0.424
2013 Bandaru VV, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ. A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 81: 1492-9. PMID 24027056 DOI: 10.1212/Wnl.0B013E3182A9565E  0.318
2013 Knopman DS, Jack CR, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis. Jama Neurology. 70: 1030-8. PMID 23797806 DOI: 10.1001/Jamaneurol.2013.182  0.415
2013 Trushina E, Dutta T, Persson XM, Mielke MM, Petersen RC. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. Plos One. 8: e63644. PMID 23700429 DOI: 10.1016/J.Jalz.2013.05.472  0.387
2013 Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR. Mild cognitive impairment due to Alzheimer disease in the community. Annals of Neurology. 74: 199-208. PMID 23686697 DOI: 10.1002/Ana.23931  0.466
2013 Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 685-95. PMID 23567400 DOI: 10.1016/J.Jagp.2013.01.006  0.433
2013 Miller VM, Garovic VD, Kantarci K, Barnes JN, Jayachandran M, Mielke MM, Joyner MJ, Shuster LT, Rocca WA. Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biology of Sex Differences. 4: 6. PMID 23537114 DOI: 10.1186/2042-6410-4-6  0.376
2013 Knopman DS, Jack CR, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. Brain injury biomarkers are not dependent on β-amyloid in normal elderly. Annals of Neurology. 73: 472-80. PMID 23424032 DOI: 10.1002/Ana.23816  0.323
2013 Leyhe T, Darreh-Shori T, Laske C, Mielke MM, Maetzler W. Biomarkers in Alzheimer's disease and lewy body disorders with dementia. International Journal of Alzheimer's Disease. 2013: 473181. PMID 23365784 DOI: 10.1155/2013/473181  0.377
2013 Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM, Petersen RC. Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women. Jama Neurology. 70: 374-82. PMID 23358884 DOI: 10.1001/Jamaneurol.2013.607  0.44
2013 Mielke MM, Roberts RO, Savica R, Cha R, Drubach DI, Christianson T, Pankratz VS, Geda YE, Machulda MM, Ivnik RJ, Knopman DS, Boeve BF, Rocca WA, Petersen RC. Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 68: 929-37. PMID 23250002 DOI: 10.1093/Gerona/Gls256  0.404
2013 Nowrangi MA, Lyketsos CG, Leoutsakos JM, Oishi K, Albert M, Mori S, Mielke MM. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 519-28. PMID 23245561 DOI: 10.1016/J.Jalz.2012.05.2186  0.407
2013 Geda YE, Ragossnig M, Roberts LA, Roberts RO, Pankratz VS, Christianson TJ, Mielke MM, Levine JA, Boeve BF, Sochor O, Tangalos EG, Knopman DS, Petersen RC. Caloric intake, aging, and mild cognitive impairment: a population-based study. Journal of Alzheimer's Disease : Jad. 34: 501-7. PMID 23234878 DOI: 10.3233/Jad-121270  0.387
2013 Vemuri P, Wiste H, Weigand S, Knopman D, Mielke M, Machulda M, Lowe V, Petersen R, Jack C. P1-282: Effect of APOE and family history of dementia on Alzheimer's disease imaging biomarkers in cognitively normal subjects Alzheimer's & Dementia. 9: P257-P257. DOI: 10.1016/J.Jalz.2013.05.507  0.426
2013 Tschanz J, Schwartz S, Gilbert M, Wanzek J, Sanders C, Mielke M, Corcoran C, Norton M, Lyketsos C. Vascular factors as predictors of severe dementia and mortality in Alzheimer's disease: The Cache County dementia progression study Alzheimers & Dementia. 9: 738. DOI: 10.1016/J.Jalz.2013.05.1484  0.39
2013 Vemuri P, Wiste H, Weigand S, Knopman D, Mielke M, Machulda M, Lowe V, Petersen R, Jack C. IC-P-136: Effect of APOE and family history of dementia on Alzheimer's imaging biomarkers in cognitively normal individuals Alzheimer's & Dementia. 9: P80-P80. DOI: 10.1016/J.Jalz.2013.05.133  0.403
2013 Vemuri P, Lesnick T, Przybelski S, Knopman D, Machulda M, Lowe V, Mielke M, Roberts R, Geda Y, Gregg B, Senjem M, Gunter J, Petersen R, Jack C. P3-217: Effect of intellectual lifestyle and Alzheimer's disease biomarkers on rate of cognitive decline: Mayo Clinic Study of Aging Alzheimer's & Dementia. 9: P635-P635. DOI: 10.1016/J.Jalz.2013.05.1290  0.345
2013 Mielke M, Wiste H, Savica R, Leibson C, Wiegand S, Knopman D, Vemuri P, Roberts R, Lowe V, Geda Y, Petersen R, Jack C. Association between head trauma, amyloid, and neurodegeneration in a population-based study of cognitively normal participants and participants with mild cognitive impairment Alzheimers & Dementia. 9: 616. DOI: 10.1016/J.Jalz.2013.05.1245  0.409
2013 Mielke M, Wiste H, Weigand S, Vemuri P, Lowe V, Machulda M, Roberts R, Knopman D, Kantarci K, Geda Y, Boeve B, Petersen R, Jack C. IC-P-028: CogState computerized testing is associated with amyloid and FDG-PET: Implications for secondary preventive trials Alzheimer's & Dementia. 9: P24-P24. DOI: 10.1016/J.Jalz.2013.05.029  0.34
2013 Mielke M, Wiste H, Savica R, Leibson C, Weigand S, Knopman D, Vemuri P, Roberts R, Lowe V, Geda Y, Petersen R, Jack C. Association between head trauma, amyloid and neurodegeneration in a population-based study of cognitively normal and mild cognitive impairment participants Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.028  0.414
2013 Knopman D, Jack C, Wiste H, Weigand S, Vemuri P, Mielke M, Roberts R, Machulda M, Lowe V, Boeve B, Kantarci K, Petersen R. Combinations of amyloid and neurodegeneration biomarkers have a differential impact on cognition Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.344  0.405
2012 Mielke MM, Haughey NJ. Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease? Clinical Lipidology. 7: 525-536. PMID 23606909 DOI: 10.2217/Clp.12.59  0.372
2012 Tighe SK, Oishi K, Mori S, Smith GS, Albert M, Lyketsos CG, Mielke MM. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. The Journal of Neuropsychiatry and Clinical Neurosciences. 24: 484-8. PMID 23224456 DOI: 10.1176/Appi.Neuropsych.11120375  0.413
2012 Mielke MM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Roberts RO, Geda YE, Swenson-Dravis DM, Boeve BF, Senjem ML, Vemuri P, Petersen RC, Jack CR. Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 79: 1570-7. PMID 22972644 DOI: 10.1212/Wnl.0B013E31826E2696  0.377
2012 Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, Albert M, Varma V, Harris G, Schneider EB, Rabins PV, Bandeen-Roche K, Lyketsos CG, Carlson MC. Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology. 79: 633-41. PMID 22815558 DOI: 10.1212/Wnl.0B013E318264E380  0.417
2012 Leoutsakos JM, Han D, Mielke MM, Forrester SN, Tschanz JT, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Lyketsos CG. Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study. International Psychogeriatrics / Ipa. 24: 1561-70. PMID 22687143 DOI: 10.1017/S104161021200049X  0.383
2012 Mielke MM, Okonkwo OC, Oishi K, Mori S, Tighe S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 105-13. PMID 22404852 DOI: 10.1016/J.Jalz.2011.05.2416  0.373
2012 Rosenberg PB, Mielke MM, Han D, Leoutsakos JS, Lyketsos CG, Rabins PV, Zandi PP, Breitner JC, Norton MC, Welsh-Bohmer KA, Zuckerman IH, Rattinger GB, Green RC, Corcoran C, Tschanz JT. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 1248-57. PMID 22374884 DOI: 10.1002/Gps.3769  0.734
2012 Mielke MM, Leoutsakos JM, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Tschanz JT, Lyketsos CG. Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 180-7. PMID 22301194 DOI: 10.1016/J.Jalz.2011.02.011  0.356
2012 Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 365-74. PMID 21848679 DOI: 10.1111/J.1552-6569.2011.00633.X  0.371
2012 Mielke MM. Shifting our focus to blood-based biomarkers of Alzheimer’s disease: the promise of ceramides and sphingomyelins Neurodegenerative Disease Management. 2: 91-94. DOI: 10.2217/Nmt.11.87  0.413
2012 Roberts R, Geda Y, Knopman D, Cha R, Pankratz V, Mielke M, Boeve B, Tangalos E, Ivnik R, Rocca W, Petersen R. Does Progression and Mortality in Mild Cognitive Impairment Vary in Men and Women? The Mayo Clinic Study of Aging (P07.155) Neurology. 78: P07.155-P07.155. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.155  0.383
2012 Geda Y, Ragossnig M, Roberts L, Roberts R, Pankratz V, Christianson T, Mielke M, Boeve B, Tangalos E, Petersen R. Caloric Intake, Aging, and Mild Cognitive Impairment: A Population-Based Study (P04.211) Neurology. 78: P04.211-P04.211. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P04.211  0.395
2012 Oishi K, Mielke M, Albert M, Lyketsos C, Mori S. Neuroanatomical Correlates of Cognitive and Neuropsychiatric Worsening in Alzheimer's Disease: Whole-Brain Longitudinal DTI Analysis (P03.092) Neurology. 78: P03.092-P03.092. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.092  0.42
2012 Knopman D, Roberts R, Pankratz V, Geda Y, Mielke M, Cha R, Boeve B, Tangalos E, Rocca W, Petersen R. Risk of Dementia in Persons Who Refused To Participate in a Longitudinal Study of Cognitive Aging (P01.083) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.083  0.42
2012 Mielke M, Savica R, Drubach D, Christianson T, Roberts R, Knopman D, Pankratz V, Boeve B, Rocca W, Petersen R. P2-169: Slow gait predicts cognitive decline: A population-based cohort study Alzheimer's & Dementia. 8: P318-P318. DOI: 10.1016/J.Jalz.2012.05.875  0.371
2012 Lanctot K, Saleem M, Ratnam Bandaru VV, Herrmann N, Swardfager W, Mielke M, Haughey N, Oh P. P2-040: Plasma ceramide concentrations are associated with change in verbal memory performance in patients undertaking cardiac rehabilitation Alzheimer's & Dementia. 8: P277-P277. DOI: 10.1016/J.Jalz.2012.05.743  0.339
2012 Rabins P, Schwartz S, Tschanz J, Corcoran C, Black B, Fauth E, Mielke M, Lyketsos C. Neuropsychiatric symptoms at baseline predict shorter time to severe dementia in a population-based sample of incident Alzheimer's disease: The Cache County Dementia Progression Study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.333  0.388
2012 Knopman D, Jack C, Wiste H, Weigand S, Vemuri P, Lowe V, Kantarci K, Ivnik R, Boeve B, Roberts R, Mielke M, Petersen R. Clinical outcomes for stages of NIA-AA preclinical Alzheimer's disease Alzheimers & Dementia. 8: 102. DOI: 10.1016/J.Jalz.2012.05.257  0.317
2012 Mielke M, Wiste H, Wiegand S, Knopman D, Lowe V, Roberts R, Swenson-Dravis D, Boeve B, Geda Y, Senjem M, Vemuri P, Petersen R, Jack C. IC-P-038: Identification of noninvasive screening variables for the prediction of amyloid accumulation in a population-based study of cognitively normal elderly individuals Alzheimer's & Dementia. 8: P25-P26. DOI: 10.1016/J.Jalz.2012.05.070  0.354
2011 Yasar S, Ko JY, Nothelle S, Mielke MM, Carlson MC. Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: the Women's Health and Aging Study II. Plos One. 6: e27976. PMID 22174760 DOI: 10.1371/Journal.Pone.0027976  0.388
2011 Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 287-96. PMID 21971468 DOI: 10.3233/Jad-2011-0007  0.377
2011 Oishi K, Akhter K, Mielke M, Ceritoglu C, Zhang J, Jiang H, Li X, Younes L, Miller MI, van Zijl PC, Albert M, Lyketsos CG, Mori S. Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Frontiers in Neurology. 2: 54. PMID 21904533 DOI: 10.3389/Fneur.2011.00054  0.396
2011 Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, Pavlik V, Doody RS, Lyketsos CG. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 27: 259-69. PMID 21841258 DOI: 10.3233/Jad-2011-110405  0.444
2011 Tschanz JT, Corcoran CD, Schwartz S, Treiber K, Green RC, Norton MC, Mielke MM, Piercy K, Steinberg M, Rabins PV, Leoutsakos JM, Welsh-Bohmer KA, Breitner JC, Lyketsos CG. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 532-42. PMID 21606896 DOI: 10.1097/Jgp.0B013E3181Faec23  0.438
2011 Mielke MM, Leoutsakos JM, Tschanz JT, Green RC, Tripodis Y, Corcoran CD, Norton MC, Lyketsos CG. Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 127-34. PMID 21593560 DOI: 10.3233/Jad-2011-110086  0.39
2011 Okonkwo OC, Mielke MM, Griffith HR, Moghekar AR, O'Brien RJ, Shaw LM, Trojanowski JQ, Albert MS. Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. Archives of Neurology. 68: 113-9. PMID 21220682 DOI: 10.1001/Archneurol.2010.334  0.411
2011 Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos JM, Lyketsos CG. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. International Journal of Geriatric Psychiatry. 26: 364-72. PMID 20845402 DOI: 10.1002/Gps.2535  0.394
2011 Mielke M, Haughey N, Bandaru VVR, Weinberg D, Zaidi N, Pavlik V, Doody R, Lyketsos C. Plasma sphingomyelin is associated with cognitive progression in Alzheimer's Disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.937  0.438
2011 Oh E, Jain A, Fedarko N, Rosenberg P, Lyketsos C, Yu Q, Mielke M, Parker D. Plasma neopterin levels in a MCI and Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.383  0.348
2011 Mielke M, Bandaru VVR, Xia J, Haughey N, Yasar S, Albert M, Varma V, Harris G, Schneider E, Bandeen-Roche K, Fried L, Lyketsos C, Carlson M. P3-283: Serum ceramides predict incident Alzheimer's disease: The women's health and aging study (WHAS) II Alzheimer's & Dementia. 7: S607-S607. DOI: 10.1016/J.Jalz.2011.05.1725  0.331
2011 Tripodis Y, Mielke M, Sherva R, Corcoran C, Tschanz J, Lyketsos C, Hendrix S, Green R. Comparison of statistical models estimating rate of decline in a population-based cohort of persons with Alzheimer's disease: The Cache County study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1708  0.331
2011 Tripodis Y, Mielke M, Sherva R, Corcoran C, Tschanz J, Welsh-Bohmer K, Breitner J, Lyketsos C, Green R. Gender modifying-effect between APOE and cognitive decline in Alzheimer's disease: The Cache County dementia progression study Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1707  0.468
2011 Mielke M, Leoutsakos J, Tschanz J, Green R, Tripodis Y, Corcoran C, Norton M, Lyketsos C. P3-256: Interaction between vascular factors and the APOE E4 allele predict rate of progression in Alzheimer's dementia Alzheimer's & Dementia. 7: S598-S598. DOI: 10.1016/J.Jalz.2011.05.1697  0.348
2011 Rabins P, Schwartz S, Tschanz J, Corcoran C, Black B, Fauth E, Mielke M, Lyketsos C. Risk factors for severe dementia from a population-based sample of incident Alzheimer's Disease: The Cache County Dementia Progression Study. Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1031  0.405
2010 Mielke MM, Zandi PP, Shao H, Waern M, Östling S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson DR. The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology. 75: 1888-95. PMID 21068429 DOI: 10.1212/Wnl.0B013E3181Feb2Bf  0.594
2010 Mielke MM, Haughey NJ, Ratnam Bandaru VV, Schech S, Carrick R, Carlson MC, Mori S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 378-85. PMID 20813340 DOI: 10.1016/J.Jalz.2010.03.014  0.423
2010 Mielke MM, Lyketsos CG. Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? Neuromolecular Medicine. 12: 331-40. PMID 20571935 DOI: 10.1007/S12017-010-8121-Y  0.36
2010 Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ, Tremont G. Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Archives of Neurology. 67: 688-96. PMID 20558388 DOI: 10.1001/Archneurol.2010.118  0.452
2010 Rosenberg PB, Mielke MM, Xue QL, Carlson MC. Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 204-11. PMID 20224517 DOI: 10.1097/Jgp.0B013E3181C53487  0.391
2010 Ewers M, Mielke MM, Hampel H. Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Experimental Gerontology. 45: 75-9. PMID 19782124 DOI: 10.1016/J.Exger.2009.09.005  0.394
2010 Mielke MM, Bandaru VV, Haughey NJ, Rabins PV, Lyketsos CG, Carlson MC. Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiology of Aging. 31: 17-24. PMID 18455839 DOI: 10.1016/J.Neurobiolaging.2008.03.011  0.404
2010 Mielke MM, Okonkwo OC, Mori S, Oishi K, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG. Fornix fractional anisotropy and hippocampal volume, alone and in combination, predict conversion from MCI to Alzheimer's disease Alzheimer's & Dementia. 6: S288. DOI: 10.1016/J.Jalz.2010.05.948  0.349
2009 Gustafson DR, Bäckman K, Waern M, Östling S, Guo X, Zandi P, Mielke MM, Bengtsson C, Skoog I. Adiposity indicators and dementia over 32 years in Sweden Neurology. 73: 1559-1566. PMID 19901247 DOI: 10.1212/Wnl.0B013E3181C0D4B6  0.568
2009 Carlson MC, Erickson KI, Kramer AF, Voss MW, Bolea N, Mielke M, McGill S, Rebok GW, Seeman T, Fried LP. Evidence for neurocognitive plasticity in at-risk older adults: the experience corps program. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 64: 1275-82. PMID 19692672 DOI: 10.1093/Gerona/Glp117  0.309
2009 Mielke MM, Kozauer NA, Chan KCG, George M, Toroney J, Zerrate M, Bandeen-Roche K, Wang MC, vanZijl P, Pekar JJ, Mori S, Lyketsos CG, Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease Neuroimage. 46: 47-55. PMID 19457371 DOI: 10.1016/J.Neuroimage.2009.01.054  0.432
2009 Schneider EB, Mielke MM, Yasar S, Carlson MC. P4-286: Statin Use Is Not Associated With Cognitive Impairment In A Cohort of Older Women Alzheimer's & Dementia. 5: e13-e14. DOI: 10.1016/J.Jalz.2009.07.067  0.384
2009 Mielke MM, Haughey N, Bandaru VVR, Miller MI, Mori S, Schech S, Albert M, Lyketsos CG. P3-040: Plasma ceramides predict hippocampal atrophy and progression in memory impairment among amnestic Mild Cognitive Impairment participants Alzheimer's & Dementia. 5: P351-P352. DOI: 10.1016/J.Jalz.2009.04.1217  0.366
2009 Tschanz JT, Corcoran CD, Green RC, Munger R, Mielke MM, Norton MC, Rabins PV, Welsh-Bohmer KA, Buckley T, Breitner JC, Lyketsos CG. P1-069: Interaction between C-Reactive protein level and APOE genotype in predicting rate of progression in Alzheimer's disease: The Cache County dementia progression study Alzheimer's & Dementia. 5: P192-P192. DOI: 10.1016/J.Jalz.2009.04.073  0.365
2008 Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 883-92. PMID 18978249 DOI: 10.1097/Jgp.0B013E318181276A  0.595
2008 Mielke MM, Xue QL, Zhou J, Chaves PH, Fried LP, Carlson MC. Baseline serum cholesterol is selectively associated with motor speed and not rates of cognitive decline: the Women's Health and Aging Study II. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 63: 619-24. PMID 18559637 DOI: 10.1093/Gerona/63.6.619  0.392
2008 Lyketsos CG, Szekely CA, Mielke MM, Rosenberg PB, Zandi PP. Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies. International Psychogeriatrics / Ipa. 20: 871-89. PMID 18498669 DOI: 10.1017/S1041610208007382  0.553
2008 Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG. Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics / Ipa. 20: 109-23. PMID 17711604 DOI: 10.1017/S104161020700587X  0.389
2008 Mielke MM, Bandaru VV, Haughey NJ, Schech S, Chu M, Albert M, Bandeen-Roche K, Lyketsos CG. P1-360: Plasma ceramides are altered early in the course of Alzheimer's disease Alzheimer's & Dementia. 4: T324-T324. DOI: 10.1016/J.Jalz.2008.05.942  0.33
2008 Tschanz JT, Corcoran C, Shao H, Zandi PP, Norton M, Mielke M, Green RC, Rabins PV, Steinberg M, Welsh-Bohmer KA, Breitner JCS, Lyketsos CG. O2-01-08: Assocation between neuropsychiatric syndromes and mortality in a population-based sample of incident Alzheimer's disease and other dementias: The Cache County dementia progression study Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.311  0.568
2007 Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 69: 1850-8. PMID 17984453 DOI: 10.1212/01.Wnl.0000279520.59792.Fe  0.59
2007 Morgan MD, Mielke MM, O'Brien R, Troncoso JC, Zonderman AB, Lyketsos CG. Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA). Alzheimer Disease and Associated Disorders. 21: 199-204. PMID 17804951 DOI: 10.1097/Wad.0B013E3181461932  0.436
2006 Mielke MM, Lyketsos CG. Lipids and the pathogenesis of Alzheimer's disease: is there a link? International Review of Psychiatry (Abingdon, England). 18: 173-86. PMID 16777671 DOI: 10.1080/09540260600583007  0.345
2006 Mielke MM, Zandi PP. Hematologic risk factors of vascular disease and their relation to dementia. Dementia and Geriatric Cognitive Disorders. 21: 335-52. PMID 16508297 DOI: 10.1159/000091789  0.549
2006 Mielke MM, Zandi PP, Blennow K, Gustafson D, Sjögren M, Rosengren L, Skoog I. Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life. Alzheimer Disease and Associated Disorders. 20: 30-6. PMID 16493233 DOI: 10.1097/01.Wad.0000201848.67954.7D  0.538
2006 Rosenberg PB, Mielke MM, Samus QM, Rosenblatt A, Baker A, Brandt J, Rabins PV, Lyketsos CG. Transition to nursing home from assisted living is not associated with dementia or dementia-related problem behaviors. Journal of the American Medical Directors Association. 7: 73-8. PMID 16461247 DOI: 10.1016/J.Jamda.2005.06.003  0.32
2006 Sjögren M, Mielke M, Gustafson D, Zandi P, Skoog I. Cholesterol and Alzheimer's disease - Is there a relation? Mechanisms of Ageing and Development. 127: 138-147. PMID 16332384 DOI: 10.1016/J.Mad.2005.09.020  0.556
2006 Harten Bv, Laman DM, Duijn Hv, Mendonça Ad, Acevedo A, Agron J, Mielke MM, Baudic S, Maison P, Jorm AF, Issacson R, Peters F, Perani D, Herholz K, Holthoff V, et al. Contents Vol. 21, 2006 Dementia and Geriatric Cognitive Disorders. 21: 415-417. DOI: 10.1159/000093311  0.427
2006 Harten Bv, Laman DM, Duijn Hv, Mendonça Ad, Acevedo A, Agron J, Mielke MM, Baudic S, Maison P, Jorm AF, Issacson R, Peters F, Perani D, Herholz K, Holthoff V, et al. Subject Index Vol. 21, 2006 Dementia and Geriatric Cognitive Disorders. 21: 413-414. DOI: 10.1159/000093310  0.445
2006 Kern S, Syrjanen J, Blennow K, Zetterberg H, Skoog I, Waern M, Hagen CE, Corien van Harten A, Knopman DS, Jack CR, Petersen RC, Mielke MM. P2-273: CEREBROSPINAL FLUID NEUROFILAMENT LIGHT PROTEIN AND RISK OF MILD COGNITIVE IMPAIRMENT IN THE MAYO CLINIC STUDY OF AGING Alzheimer's & Dementia. 14: P782-P782. DOI: 10.1016/J.Jalz.2018.06.962  0.385
2006 Mielke MM. FTS4-01-04: CHALLENGES IN USING CSF BIOMARKERS FOR OPERATIONALIZING THE NIA-AA AD RESEARCH FRAMEWORK Alzheimer's & Dementia. 14: P1399-P1399. DOI: 10.1016/J.Jalz.2018.06.2904  0.312
2006 Radford JG, Vemuri P, Rabinstein A, Przybelski SA, Lesnick TG, Flemming K, Brown RD, Knopman DS, Roberts RO, Mielke MM, Kremers WK, Jones DT, Huston J, Lowe VJ, Petersen RC, et al. O2-13-01: INCIDENCE OF CEREBRAL MICROBLEEDS AND AMYLOID BURDEN: THE MAYO CLINIC STUDY OF AGING Alzheimer's & Dementia. 14: P652-P652. DOI: 10.1016/J.Jalz.2018.06.2712  0.308
2006 Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Boeve BF, Jones DT, Albertson SM, Petersen RC, Jack CR. O1-03-05: ENTORHINAL CORTEX TAU PET, CORTICAL THICKNESS AND MEMORY PERFORMANCE IN COGNITIVELY UNIMPAIRED PERSONS Alzheimer's & Dementia. 14: P221-P222. DOI: 10.1016/J.Jalz.2018.06.2346  0.319
2006 Arenaza-Urquijo EM, Przybelski SA, Machulda MM, Knopman DS, Lowe VJ, Mielke MM, Radford JG, Petersen RC, Jack CR, Vemuri P. IC-P-116: COGNITIVE RESILIENCE IN 80+: PREDICTORS AND IMAGING CORRELATES OF COGNITION Alzheimer's & Dementia. 14: P99-P100. DOI: 10.1016/J.Jalz.2018.06.2182  0.367
2006 Mielke MM, Syrjanen J, Blennow K, Zetterberg H, Kern S, Skoog I, Machulda MM, Hagen CE, Knopman DS, Jack CR, Petersen RC. P3-238: LONGITUDINAL ASSOCIATIONS OF PLASMA NEUROFILAMENT LEVELS WITH AMYLOID-PET, FDG-PET, AND COGNITION AMONG NON-DEMENTED PARTICIPANTS IN THE MAYO CLINIC STUDY ON AGING Alzheimer's & Dementia. 14: P1163-P1164. DOI: 10.1016/J.Jalz.2018.06.1597  0.366
2006 Stricker NH, Lundt ES, Albertson SM, Machulda MM, Jack CR, Knopman DS, Petersen RC, Mielke MM. P2-491: SUBTLE COGNITIVE DYSFUNCTION ON COGSTATE IS ASSOCIATED WITH BIOMARKER POSITIVE STATUS Alzheimer's & Dementia. 14: P917-P918. DOI: 10.1016/J.Jalz.2018.06.1184  0.384
2006 Tschanz JT, Cook L, Corcoran C, Norton M, Mielke M, Rosenberg P, Buckley T, Clay C, Welsh-Bohmer K, Breitner J, Lyketsos C. P2-126: Vascular factors and the rate of cognitive decline in dementia. The Cache County Study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.964  0.402
2006 Zandi PP, Mielke MM, Shao H, Guo X, Waern M, Sacuiu S, Ostling S, Gustafson D, Skoog I. O2-06-06: The association of cholesterol with dementia over time in the prospective population study of women in Gothenburg, Sweden Alzheimer's & Dementia. 2: S43-S44. DOI: 10.1016/J.Jalz.2006.05.152  0.521
2005 Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B, Skoog I. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 64: 1689-95. PMID 15911792 DOI: 10.1212/01.Wnl.0000161870.78572.A5  0.548
2005 Rosenberg PB, Mielke MM, Lyketsos CG. Caregiver Assessment of Patients' Depression in Alzheimer Disease: Longitudinal Analysis in a Drug Treatment Study The American Journal of Geriatric Psychiatry. 13: 822-826. DOI: 10.1097/00019442-200509000-00012  0.305
2004 Mielke MM, Zandi PP, Gustafson D, Sjogren K, Guo X, Skoog I. P2-264 High serum total cholesterol in mid- and late-life associated with incident dementia in younger, but not older cohorts of women Neurobiology of Aging. 25: S307. DOI: 10.1016/S0197-4580(04)81009-1  0.535
Show low-probability matches.